Search This Blog

Wednesday, February 27, 2019

ANI Pharmaceuticals sees FY19 non-GAAP EPS $5.57-$6.21, consensus $5.79

Sees FY19 revenues $231M-$245M, consensus $243.37M.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.